GHOLAMREZA POURMAND Current Position: Dean of Sina University Hospital
Tehran University of Medical Sciences
Contact Information:
Academic Rank:Full Professor[Full GMC Registration (UK): 2876340]
Department:Urology
Address: Imam Khomeini St., Hassan Abad Sq., Sina Hospital
Tel (Office): (+9821) 66717447
Telefax: (+9821) 667 1 6545 – 6
E-mail:[email protected]
Education:
1992 – 1993
Fellowship in “Renal Transplantation”
Middlesex Hospital
London – UK
1984 – 1985
Fellowship in “Male Infertility & Urologic Oncology ”
University of California Los Angeles (UCLA)
California - USA
1974 – 1978
Course of Specialty in “General Surgery & Urology”
Tehran University of Medical Sciences
Tehran – Iran
1965 – 1972
General Medicine (MD)
Ahvaz University of Medical Sciences
Ahvaz – Iran
Further Training Courses:
August 2-4, 2010 AkademiKA Program about "Principles of Good Clinical Practice",
Turkey
May 15-18, 2006Nanomedicine (Short Visit), Moscow – Russia
March 10-18, 2006 Nanomedicine (Short Course), Moscow – Russia
1998 Reproductive (Short Course), Brussels – Belgium
1992-1993 Laparoscopic Urology, King’s College School of Medicine and
Dentistry, UK
1992-1993 Renal transplantation, Middlesex Hospital, London – UK
1984Male infertility, 3 months, U.C.L.A., U.S.A.
1984Urology Oncology and Pediatric Urology, 6 months, Buffalo & U.C.L.A., U.S.A.
1984Renal Transplantation, 3 months, Guy’s Hospital, London – UK
1982Neurogenic Bladder(Short Course), West Germany
1977A Short Course of Urology & Nephrology, 3 months, Institute of Urology& Nephrology,
London – UK
Highlighted Educational/Professional Qualifications:
• The 3rdFestival of Eternal Faces, 2006
Professional Society Membership:
1990 – Present The European Association of Urology
1988 – Present The American Urologic Association (Corresponding Member)
1988 – Present The International Society of Urology (Iranian Delegate)
1972 – Present The Iranian Medical Council
Work Experience:
Executive Activities
• 2010:Head of the Specialized Committee of Surgical, Clinical Sciences, 16thRazi Medical
Sciences Research Festival
• 2010:Member of Examining Board of Oral OSCE, 57th Urology Board Examination
• 2005 – Present:The Secretary General of Clinical Research Committee, The 11thFestival
of National Research Center of Medical Sciences of Iran
• 2005 - Present:Dean of Sina University Hospital
• 2005:Member of Distinguished Iranian Professors
• 2003 - Present:Director of Urology Research Center, Tehran University of Medical
Sciences
• 2003 – Present:Member of Nanotechnology Committee, Ministry of Health, Treatment
and Medical Education
• 2002 – Present:Iranian Councilor for the Middle East Organ Transplantation Society
• 2001 – Present:Member of Clinical Sciences Committee, Ministry of Health, Treatment
andMedical Education
• 2001 – Present:Member of Medical Instruments Committee, Ministry of Health,
Treatment and Medical Education
• 2000 – Present:Consultant Member of the Academy of Medical Sciences
• 1990 – Present:Member of the Counseling Board of the Medical Journal of Islamic
Republic of Iran
• 1990 – Present:Member of the European Association of Urology
• 1989 – Present:Professor Delegate of SIU
• 1988 – Present:Corresponding member of the American Urological Association
• 1980 – Present: Member of the Supreme Medical Council, Ministry of Health
• 2001:Clinical Sciences Research Programming Committee, Ministry of Health,
Treatment and Medical Education
• 1993 – 1997:Vice Chancellor for Research, Tehran University of Medical Sciences
• 1990 – 1992:Secretary General of the Iranian Kidney Transplant Foundation
• 1990 – 1993:Member of the American Fertility Society
• 1990 – 1992:Deputy Dean in Research, Tehran Medical Faculty
• 1988 – 1992: Chairman of Urology Department, Tehran University – Medical Faculty
• 1985 – 1993:Head of Urology Department, Sina University Hospital
• 1982 – 1985: Vice – Chairman of the Iranian Urological Association
Editorial Activities
• Editorial board member of the Iranian Journal of Reproductive Medicine (2004)
• Editorial board member of Pejouhesh Journal of the Faculty of Medicine (2000)
• Urology journal official of the Journal of the Urology and Nephrology Research Center
and the Iranian Urological Association (2002)
• Editor of Acta Medical Iranica, Medical Journal of Tehran University (1990-1997)
• Editorial board member of ActaMedicaIranica (1976)
• Editorial board member of the Medical Journal of Tehran University of Medical Sciences
(1976)
• Editorial board member of the Iranian Journal of Reproductive Medicine
Clinical Activities
1978 1978 1978 1978 –––– PresentPresentPresentPresent
SINA UNIVERSITY HOSPITAL
Urologist
Tehran – Iran
1972 1972 1972 1972 –––– 1974197419741974
AIR FORCE (Military Service)
1st Lieutenant – General Practitioner
Tehran – Iran
Teaching Service
1995199519951995 –––– Present Present Present Present
TEHRAN UNIVERSITY OF MEDICAL SCIENCES
Full Professor
Tehran – Iran
1986198619861986 –––– 1994199419941994
TEHRAN UNIVERSITY OF MEDICAL SCIENCES
Associate Professor
Tehran – Iran
1978197819781978 –––– 1986198619861986
TEHRAN UNIVERSITY OF MEDICAL SCIENCES
Assistant Professor
Tehran – Iran
Thesis:
1. Hedayatifar SH, Evaluating clinical trend, results and outcomes of kidney transplant in
patients operated in Sina Hospital (1999-2008), Specialty course of “Urology Surgery”,
June 2010 (Advisor)
2. Mansouri S, Evaluatingvaginal delivery urologic complications, Specialty course of
“Urology Surgery”, 2010 (Consultant)
3. Shaeikh-al-Eslami, Evaluating the effect of pentoxifilinon clinical signs and IL-6
decrease following torsion in male rats and comparing it to control group, General
Medicine, 2008 (Consultant)
4. Allameh F, Evaluating the effect of sex hormones in the incidence of prostate cancer,
General Medicine, 2009 (Advisor)
5. MohseniLangroudi M, Evaluating the effect of meat, garlic and tomato (licopen) on
prostate cancer,General Medicine, 2009(Advisor)
6. Ranjbar M, Evaluating the number of IFN-γ, IL-10, IL-17 cytokine secreting cells and
determining the percentage of subcategories of T-adjusting cells
(CD4+CD25+FoxP3+CD3+CD8+CD28-) in kidney transplant patients,"Immunology"
MSc. thesis, 2010 (Advisor)
7. Solgi GH, Effect of injecting donor's bone marrow cells on chimerism and renal
transplant outcome prognosis, "Immunology" PhD dissertation,2010 (Consultant)
8. Mahdiani M, Evaluating the relationship between hs-CRP serum level and renal graft
survival during the first post-kidney-transplant year in Sina Hospital in the second fall
and winter, 2007, Specialty course of “Urology Surgery”,2010 (Consultant)
9. Daneshpajouh A, Evaluating the treatment effects of intra-prostate toxin botulinum
Type A injection in prostate benign hyperplasia, Specialty course of “Urology Surgery”,
2009 (Consultant)
10. Shahnazari A, Evaluating predictive factors for the presence of a motile sperm in
testicles of non-obstructiveazoospermic patients, Specialty course of “Urology
Surgery”,June 2010 (Advisor)
11. Hosseini, M, Evaluating the effect of corrected calcium levels on the incidence of
prostate cancer, General Medicine, 2010 (Advisor)
12. Shokouhideh V, Evaluating the relationship between erectile disorders and risk factors
in patients with coronary vascular disease among patients referred to the angiography
department of Day General Hospital (2008), Specialty course of “Urology Surgery”,
2010 (Advisor)
13. Family P, Ahmadi H, Evaluating the effect of vasectomy, sexual behaviors and
infections of the urinary system on the incidence of prostate cancer, General Medicine,
2008 (Advisor)
14. Abedi AR, Studying prostates cancer progress and prognosis based on PTEN, PSA and
Gleason Score, Specialty course of “Urology Surgery”, 2007 (Advisor)
15. Goudarzi M, Evaluating the effect of pentoxyphyllin on clinical signs and the
comparison of the reduction rate of TNF a after torsion in male rats and a control
group, General Medicine, 2007 (Consultant)
16. Khansari M, Evaluating the effect of estrogenic, progesterone and androgenic
recipients on progress and prognosis of bladder cancer and their relationship in
patients referred to Sina, Shariati and Imam Khomeini Hospitals (March 2001 –
October 2005), General Medicine, 2007 (Advisor)
17. Ghobadi E, Afshar M, Evaluating the effect of low power helium-neon laser on
secretion rate of effective cytokines of chronic transplantation pain in a culture gel,
General Medicine, 2007 (Advisor)
18. Salahi M, MohseniLangroudi M, Evaluating the effect of 17 risk factors on the
incidence of prostate cancer in Isfahan province, General Medicine, 2007 (Advisor)
19. Hosseini M, Evaluating the effect of modified amounts of calcium on the incident of
prostate cancer, General Medicine, 2007 (Advisor)
20. Sabouri B, Evaluating the effect of 16 risk factors on the incidence of prostate cancer,
General Medicine, 2007 (Advisor)
21. Ghorbani A, Searching mutations in agxt among Iranian patients suspicious of a type
of primary hyperoxaluria, Master’s Degree, 2006 (Consultant)
22. Naseh HR, Comparing urine facilitators, blockers and proteins of patients having renal
stones with healthy people (2002), Specialty course of “Urology Surgery”, 2005
(Advisor)
23. Mousavi SH, Comparing sexual impotency in groups including healthy people, patients
with renal dysfunction undergoing hemodialysis and kidney transplant recipients,
Specialty course of “Urology Surgery”, 2005 (Advisor)
24. Seraji A, The retrospective study of the role of microchimerism in graft survival of
female recipients who received kidney from males in Sina Kidney Transplant Research
Center (Sina Hospital) (1993-2002), Specialty course of “Urology Surgery”,
2003(Advisor)
25. Salem S, Evaluating the prevalence of infections during the 1st year following kidney
transplant in 100 cases in Sina Hospital (2002-2003), General Medicine, 2003(Advisor)
26. Jalalizadeh B, Evaluating the stability of chromatin in infertile patients with spinal and
vascular lesions (varicocell) and healthy males referred to MirzaKouchak Khan and
Sina Hospitals and Kosar Medical Center (2002-2003), Specialty course of “Urology
Surgery”, 2003 (Advisor)
27. Sina A, The study of Y-chromosome microdeletion in patients referred to Sina and
MirzaKhouchak Khan Hospitals with non-onstructive idiopathic azospermia (1999-
2000), Specialty course of “Urology Surgery”, 2002 (Advisor)
28. Jaladat H, Studying the prevalence of anti-sperm antibody (IgA, IgG) in serum and
semen of patients with varicocell referred to Sina Hospital in 2002 before and 6months
after varicocelectomy, Specialty course of “Urology Surgery”, 2002 (Advisor)
29. Baradaran N, Evaluating the effect of developing diabetes on the incidence of prostate
cancer, General Medicine, 2002 (Advisor)
30. Shoari M, Evaluating the frequency of diabetes mellitus or its increase following
kidney transplant and the how’s of its distribution according to some suggested factors
in patients operated in Sina Hospital (2007-2009), General Medicine, 2001 (Advisor)
31. Hashemian E, Evaluating the bone density in patients with kidney stone and comparing
the results with a control group, General Medicine, 2001 (Advisor)
32. Sadri M, Evaluating the effect of varicocelectomy on exact sperm morphology of
patients referred to Sina Hospital with varicocell (1998-2000), Specialty course of
“Urology Surgery”, 2000 (Advisor)
33. Haghshenas KH, Evaluating prognostic factors following Vedns surgery in
Venogenomicempote patients in Sina Hospital (1993-1998), Specialty course of
“Urology Surgery”, 1998 (Advisor)
34. ZohrehvandR, Comparing the quality of sperm test and the amount of sexual hormones
before and after kidney transplant in male receivers operated in Sina Hospital (1998-
1999), Specialty course of “Urology Surgery”, 1998 (Advisor)
35. Amidi A, Evaluating kidney damages by NAG and AAP urinary enzymes in patients
treated by ESWL, Specialty course of “Urology Surgery”, 1996 (Advisor)
36. Taheri M, Studying therapeutical effects of PygeumAfricanum essence on prostate
adenoma in Sina Hospital, Specialty course of “Urology Surgery”, 1996 (Advisor)
37. Afshar K, Evaluating serum lipoprotein changes in kidney transplant, Specialty course
of “Urology Surgery”, 1995 (Advisor)
38. Hematian MA, Evaluating kidney function after breaking the stones using renogram,
radionuclide and DTPA, Specialty course of “Urology Surgery”, 1995(Advisor)
39. KalhoriSH, The bacteriological evaluation of the central core of renal stones, Specialty
course of “Urology Surgery”, 1994 (Advisor)
40. Mokhtari GH, Urologic complications of gynecological surgeries, Specialty course of
“Urology Surgery”, 1993(Advisor)
41. Eshraghi B, The effect of diagnosis & treatment of papaverine in treating male
infertility , Specialty course of “Urology Surgery”, 1991 (Advisor)
42. Afshar K, Evaluating ESWL results performed in Sina Hospital ,General Medicine,
1991 (Advisor)
43. JamaliPaghal’e M, Pyeloplasty and comparing Tubating Vs. Tubeless surgical methods
in its treatment, Specialty course of “Urology Surgery”, 1991(Advisor)
44. Rafie B, Analyzing chemical renal stones (1987-88), General Medicine, 1988 (Advisor)
Research Interests:
• Nanotechnology
• Prostate Cancer
• Kidney Transplantation
Research Projects:
Ongoing
• Comparison of cut-off value for total prostate-specific antigen and free to total
prostate-specific antigen ratio with international standards in s multi-centric study
• Study of erectile dysfunction treatment in andropause patients according to serum
testosterone level
Completed
• Plasma adiponectin concentration before and after kidney transplantation
• The evaluation of clinical and laboratory changes after varicocelectomy
• Prostate cancer in Iran, risk factors
• CMV in transplanted kidney
• The role of microchimerism in graft survival of female recipients who received
kidney from males (aretrospective study), November 1993 – August 2002
• “Erectile Dysfunction in patients with coronary artery disease andrisk of coronary
artery disease in patients with erectile dysfunction", is there any correlation?
• The incidence of infection in the first year after renal transplantation in 100 patients
in Sina hospital
• Evaluating the progression and outcome of prostate carcinoma with regard to PSA,
Gleason score and PTEN gene
• The prevalence of urinarytract infection before and after simple prostatectomy
(TURP, open)
• The population based evaluation of correlation between risk factors and prostate
cancer [Multi centric case–control study]
• Evaluating the efficacy of Nandrolone (injectable androgen)in decreasing
bothersome symptoms after surgery for BPH
• The evaluation of progression of prostate carcinoma based on Gleason score and
pathologic stage
• Study and comparison of effects of living donor bone marrow cells infusion on
kidney recipient and graft survival with control group.
Publications:
• Articles
� English
1. Pourmand G, Solgi GH. Augmentation of chimerism by donor bone marrow cells
infusion in kidney allograft recipients.European Urology Supplements, 10 (2): 134
,2011
2. Salem S, Salahi M, Mohseni M, Mehrsai AR, Jahani Y, Pourmand G. Major dietary
factors and prostate cancer risk: A prospective multi-cancer case-control
study.Nutrition & Cancer, 00 (0): 1-7 ,November 22, 2010& Nutr Cancer, 63(1):21-7,
January 2011
3. Mirfakhraie R, Kalantar SM, Mirzajani F, Montazeri M, Salsabili N, Houshmand M,
Hashemi-Gorji F,Pourmand G.A Novel Mutation in the Transactivation-
Regulating Domain of the Androgen Receptor in a Patient with Azoospermia. J
Androl., December 2, 2010 [PMID:21127309]
4. Ahmadi H, Allameh F, Baradaran N, MontaserKouhsari L, BazarganHejazu SH,
Salem S, Mehrsai AR, Pourmand G. Circulating sex hormones play no role in the
association between sexual activity and the risk of prostate cancer .J Sex Med,
November 22, 2010 (doi: 10.1111/j.1743-6109.2010.02115.x.) [PMID:21091879]
5. Razeghi E, Heydarian P, Amerian M, Pourmand G. The risk factors for diabetes
mellitus after kidney transplantation.Saudi J Kidney Dis Transpl., 21(6): 1038-1043,
November 21, 2010 [PMID:21060170]
6. Mirfakhraie R., Mirzajani F., Kalantar M., Montazeri M., Salsabili N.,Pourmand G.,
HoushmandM.High prevalence of AZFbmicrodeletion in Iranian patients with
idiopathic non-obstructive azzospermia.Indian J Med Res. P. 256-270, September
2010
7. Pourmand G, Seraji A., Dehghani S., Mehrsai A., Nikoobakht M., Talibnajad M.,
Razeghi E., Rahbar M., Hosseini H., Pourmand N., Poumand Sh., Zahedikia M.,
Porhussein M., Heidari F. Should post-kidney transplantation hyperlipidemia
considered a risk factor for graft function?International Journal of Organ
Transplantation Medicine. Vol. 1, No. 3, July 2010
8. Nikoobakht M, Daneshpajooh A, Ahmadi H, Namdari F, Rezaeidanesh M, Amini
S,Pourmand G. Intraprostatic botulinum toxin type A injection for the treatment
of benign prostatic hyperplasia: Initial experience with Dysport.Scand J
UrolNephrol.,44(3):151-7, April 2010[PMID:20201752]
9. Salem S, Mehrsai A, Zartab H, Shahdadi N,Pourmand G. Effect of Penile-Extender
Device in Increasing Penile Size in Men with Shortened Penis: Preliminary
Results.Urol Res.,April 2010[Epub: December 17, 2010; PMID:20016885]
10. Solgi G, Pourmand G, Mehrsai A, Taherimahmoudi M, Nicknam MH, Ebrahimi
Rad MR, Seraji A, Asadpoor A, Ansaripor B, Nikbin B, Amirzargar A. Anti-HLA
antibodies and kidney allograft outcomes in recipients with donor bone marrow cell
infusion.Iran J Immunol.,7(1):18-29, March 2010[PMID:20371916]
11. Pourmand G, Abedi AR, Karami AA, Khashayar P, Mehrsai AR. Urinary infection
before and after prostatectomy.Saudi J Kidney Dis Transpl.,21(2):290-4, March
2010[PMID:20228515]
12. Nikoobakht M, Shahnazari A, Rezaeidanesh M, Mehrsai A,Pourmand G. Effect of
Penile-Extender Device in Increasing Penile Size in Men with Shortened Penis:
Preliminary Results.J Sex Med.,January 19, 2010[PMID:20102448]
13. Mahmoodi M, Aghamohammadi A, Rezaei N, Lessan-Pezeshki M,Pourmand G.
Erectile dysfunction severity as a risk predictor for coronary artery disease.J Sex
Med.,December 06, 2009 [Epub: September30, 2009; PMID:19796020]
14. Salem S, Abdi S, Mehrsai A, Saboury B, Saraji A, Shokohideh V,Pourmand G,
Mohagheghi MA, Abdollahzade S, Mousavi-Jarrahi A.Antibody response to
pneumococcal capsular polysaccharide vaccination in patients with chronic kidney
disease.Eur Cytokine Netw.,20(2):69-74, June 2009 [PMID:19541592]
15. Mehrsai A., Afsharpad M.I.,Afsharpad M.A.,MohydinM., AnsariB., Pourmand G.,
Nikbin B. The effect of low-level helium-neon (HeNe) laser radiation on the
secretion of cytokines that promote chronic graft rejection – An in vitro
study.Medical Laser Application, March 2009
16. Pourmand, G. Anabolic-androgenic steroid effects on early morbid symptoms after
open prostectomy: A pilot study. Aging Male. 11 (3): 123-7, September 2008
[PMID:18821287]
17. Pourmand, G. The effect of successful renal transplantation on erectile
dysfunction. The Journal of Urology. Vol. 179,No. 4,Supplement:691,May 21, 2008
18. Pourmand G. Extracorporeal shock wave lithotripsy and its effect on renal
functionassessed by 99m Technetium Dethylene-Tiamine-
PentaaceticacidScintigraphy.The Journal of Urology. Vol. 179,No.
4,Supplement:464,May 20, 2008
19. Karimianpour N, Mousavi-Shafaei P, Ziaee AA, Akbari MT,Pourmand G, Abedi A,
Ahmadi A, AfshinAlavi H.Mutations of RAS gene family in specimens of bladder
cancer.Urol J.,5(4):237-42, Fall 2008 [PMID:19101897]
20. Pourmand G, Salem S, Moradi K, Nikoobakht MR, Tajik P, Mehrsai A. Serum
Selenium level and prostate cancer: a case-control study. Nutrition & Cancer. 60 (2):
171 – 176, 2008[PMID:18444148]
21. Pourmand, G. Extracorporeal shock wave lithotripsy in adults:results and short-
term complications.EurUrol Suppl., 7(3):81, 2008
22. PourmandG. Infectious complications after kidney transplantation: a single-center
experience.Transpl Infect Dis., 9(4):302-9,December 2007
23. Pourmand G, Salem S, Mehrsai A, Lotfi M, Amirzargar MA, Mazdak H, Roshani A,
Kheirollahi A, Kalantar E, Baradaran N, Saboury B, Allameh F, Karami A, Ahmadi
H, Jahani Y.The Risk Factors of Prostate Cancer: A Multicentric Case-Control
study in Iran. Asian Pacific Journal of Cancer Prevention, 8(3):422-8, July –
September 2007 [PMID: 18159981]
24. Pourmand G. The risk factors and laboratory diagnostics for post renal transplant
Tuberculosis: a case-control, country-wide study on definitive cases.Transpl Infect
Dis. Jul 26, 2007
25. Pourmand G. Does donor nephron mass have any impact on graft survival?
Transplant Proc., 39(4):914-6,May 2007
26. Pourmand G.Microchimerism and renal transplantation: doubt still
persists.Transplant Proc., 39(4):948-50,May 2007
27. Pourmand G. Clinical manifestation, laboratory findings, and the response of
treatment in kidney transplant recipients with CMV infection.Transplant
Proc.,39(4):993-6,May2007
28. Pourmand G. Does renal transplantation improve erectile dysfunction in
hemodialysed patients? What is the role of associated factors?Transplant
Proc.,39(4):1029-32,May2007
29. Pourmand, G. Pelvic nerve neuropathy after kidney transplantation.Transplant
Proc.,39(4):1108-10,May 2007
30. Pourmand G. Pharmacokinetics, efficacy, and safety of Iminoral compared with
Neoral in healthy volunteers and renal transplant recipients.Transplant
Proc.,39(4):1214-8, May2007
31. Pourmand G, Ziaee AA, Abedi AR, Mehrsai A, Alavi HA, Ahmadi A, Saadati
HR.Role of PTEN gene in progression of prostate cancer. Urology Journal.,4(2):95-
100, Spring 2007[PMID: 17701929]
32. Mehrsai A, Djaladat H, Salem S, Jahangiri R, Pourmand G. Outcome of buccal
mucosal graft urethroplasty for long and repeated stricture repair. Urology,
69(1):17-21,Discussion 21, January 2007[PMID: 17270600]
33. Pourmand G, Nasseh H, Sarrafnejad A, Mojtahedi A, Mehrsai A, Alamdari DH,
Nourijelyani K. Comparison of urinary proteins in calcium stone formers and
healthy individuals: A case- control study, UrologiaInternaionalis,76(2):163-8,
2006[PMID: 16493220]
34. Pourmand G.Selective evaluation of two urinary enzymes (NAG and AAP) before
and after unilateral shock wave lithotripsy. ActaMedicaIranica, Vol 44, No 5,: 299-
305,2006
35. Djaladat H, Mehrsai A, Rezazade M, Djaladat Y, Pourmand G. Varicocele and
Antisperm Antibody: fact or fiction? Southern medical Journal, 99(1):44-7, January
2006[PMID: 16466121]
36. Djaladat H, Mehrsai A, Saraji A, Moosavi S, Djaladat Y, Pourmand G. Suprapubic
prostatectomy with a novel catheter. J Urol., 175(6):2083-6, June 2006[PMID: 16697808]
37. Pourmand G. Improvement of erectile dysfunction after kidney transplantation,
The role of the associated factors.Urology Journal Vol 3, No 4, Autumn 2006: 240-
244
38. Mousavi S, Mehrsai A, Nikoobakht M, Abedi AR, Salem S, Pourmand G.A Giant
congenital posterior urethral diverticulum associated with renal dysplasia.Urol J.,
3(4):247-9, Autumn 2006[PMID: 17559051]
39. Pourmand G. Post transplant infectious complications: A prospective study on 142
kidney allograft recipients. Urology Journal, Vol. 3, No. 1, 23-31, 2006
40. Salsabili N, Mehrsai A, Jalalizadeh B, Pourmand G, Jalaie S.Correlation of sperm
nuclear chromatin condensation staining method with semen parameters and
sperm functional tests in patients with spinal cord injury, varicocele, and idiopathic
infertility . Urol J., 3(1):32-7, Winter 2006 [PMID: 17590850]
41. Pourmand G, Pourmand M, Salem S, Mehrsai A, TaheriMahmoudi M, Nikoobakht
M, Ebrahimi R, Saraji A, Moosavi S, Saboury B.Posttransplant infectious
complications: a prospective study on 142 kidney allograft recipients. Urol J.,
3(1):23-31, Winter 2006 [PMID: 17590849]
42. Mehrsai A, Mousavi S, Nikoobakht M, Khanlarpoor T, Shekarpour L, Pourmand
G.Posttransplant infectious complications: a prospective study on 142 kidney
allograft recipients. Urol J., 3(4):240-4, Fall 2006 [PMID: 17559049]
43. Djaladat H, Mehrsai A, Nasseh H, Pourmand G. Synchronous renal fossa recurrence
with bladder metastases due to renal cell carcinoma.Urol J., 2(3):169-70, Summer
2005[PMID: 17602423]
44. Mehrsai A, Djaladat H, Sina A, Salem S, Pourmand G. Buccal mucosal graft in
repeat urethroplasty. Urol J., 2(4):206-10, Autumn 2005 [PMID: 17602431]
45. Pourmand G, Nasseh H, Sarrafnejad A, Mehrsai A, HamidiAlamdari D,
Nourijelyani K, Shekarpour L.Urinary Tamm-Horsfall protein and citrate: A case-
contral study of inhibitors and promoters of calcium stone formation. Urology
Journal, 2(2):79-85, Spring 2005 [PMID: 17629875]
46. Pourmand G. Molecular detection of prostate specific antigen in patients with
prostated cancer or benign prostate hyperplasia the first investigation from Iran.
Iranian Journal of Public Health, Vol. 34(3): 20-26, 2005
47. Pourmand G, Alidaee MR, Rasuli S, Maleki A, Mehrsai A. Do cigarette smokers
with erectile dysfunction benefit from stopping? A prospective study. BJU
International, 94(9):1310-3, December 2004 [PMID: 15610111]
48. Pourmand G. Preliminary report of a nationwide case-control study for
indentifying risk factors of tuberculosis following renal transplantation.
Transplantation Proceedings, 37(7): 3041-4, September 2005
49. Nikbin B., Tajik N., Saraji A, Pourmand G, Talebian F., Mehrsai A., Amirzargr A.
Microchimerism& renal tranplantatin: Doubt still persists.IJI. Vol. 1, No. 3,
Autumn 2004
50. Mehrsai A, TaghizadehAfshar A, Zohrevand R, Djaladat H, Steffes H, Hesse A,
Pourmand G. Evaluation of urinary calculi by infrared spectroscopy. Urology
Journal, 1(3):191-4, Summer 2004[PMID: 17914687]
51. Pourmand G. Epidemiologic study of 284 patients with urogenital trauma in three
trauma centers in Tehran. Urology Journal, Vol. 2, 117-120, Spring 2004
52. Pourmand G. Epidemiologic study of 284 patients with urogenital trauma in three
trauma centers in Tehran. Urology Journal, Vol. 2, 117-120, Spring 2004
53. Pourmand G. Comparison between clinical and pathologic staging in patients with
bladder cancer. Urology Journal, Vol. 2, 85-89, Spring 2004
54. Pourmand G. Management of Peyronie’s disease by dermal grafting. Urology
Journal, Vol. 2, 99-102, Spring 2004
55. Pourmand G. Effect of renal transplantation on sperm quality and sex hormone
levels. BJU international, Vol. 92, 281-283, 2003
56. Pourmand G. Effect of grapefruit juice on serum concentration of cyclosporine in
Iranian renal transplant patients. Transplantation Proceedings, 35: 2739-2741, 2003
57. Pourmand G. Outcome of 18 cases of simultaneous kidney and donor- specific
bone marrow transplantation. Transplantation Proceedings, 35: 2761-2762, 2003
58. PourmandG.Omission of azathioprine and mycophenolatemofetil in
immunosuppressive regiment in kidney transplantation.Transplantation
Proceedings, 35: 2752-2753, 2003
59. Pourmand G. Prevalence of Y chromosome microdeletions in Iranian infertile
men. ActaMedicaIranica, Vol. 41, No.3, 164-169, 2003
60. Pourmand G. Prospective study of microchimerism in renal allograft recipients:
association between HLA DR matching, microchimerism and acute rejection.
Kidney Transplantation, 15:192-198, 2001
61. Pourmand G. Impact of donor nephron mass on outcomes in renal
transplantation. Transplantation Proceedings, 33: 2828-2829, 2001
62. Pourmand G. Evaluation of endourological interventions used to treat urological
complications in 394 kidney recipients. Transplantation Proceedings, 32(3): 524-5,
May 2000
63. Pourmand G. Patient blood Glucose levels before and after kidney transplantation.
Transplantation Proceedings, 32(3): 566-8, May 2000
64. Pourmand G. The prevalence of infected stones in the urinary tract and their
relationship to urease positive bacteria. Journal of Nep-urol and transplantation, Vol.
1. No. 1. (5-8), January 2000
65. Pourmand G. Evaluation of the clinical and urodynamic effects of
pygeumafricanum (tadenan) in the treatement of benign prostatic hyperplasia
(BPH). British Journal of Urology, 1997; 80 (Suppl.2), p.227
66. Pourmand G. Traumatic rupture of penile tunica albuginea: management and
impact on erectile function. British Journal of Urology, 1997; 80 (Suppl.2), p.99
67. Pourmand G. Bacteriuria and extracorporeal shock wave lithotripsy, prophylaxis
and treatmentBritish Journal of Urology, 1997; 80 (Suppl.2), p.332
68. Pourmand G. Evaluation of acute kidney rejection in 151 recipientsBritish Journal
of Urology, 1997; 80 (Suppl.2), p.147
69. Pourmand G. Extracorporeal shock wave lithotripsy in horseshoe kidneysBritish
Journal of Urology, 1997; 80 (Suppl.2), p.333
70. Pourmand G. Congenital Ureteric Valve associated with renal dysgenesis. British
Journal of Urology, Vol.61. 362-363, April 1988
71. Pourmand G. Evaluation of surgical complications in 151 transplanted kidneys.
Transplant proceedings, 1998
72. Pourmand G. Twenty two Cases of simultaneous heart, liver and kidney transplant
from established brain dead patients. Transplant proceedings, 30 773-774, 1998
73. Pourmand G. Lipids and lipoproteins alteration after renal transplantation.
Nephrology Dialysis Transplantation. 12 (1): 233-4, January1997
74. Pourmand G. Nocardiosis: Report of four cases in renal transplant recipients.
Transplantation Proceedings Vol. 27, No.5:2731-2733, October 1995
75. Pourmand G. Urinary tract obstruction following ESWL. Acta Medical Iranica,
Vol. 32: No. 1 (22) 1-11, 1994
76. Pourmand G. Laparoscopy in Urology. Acta Medical Iranica, Vol. 32, 101-109,
1994
77. Pourmand G. Kibrick test in Vasovasectomy, ACTA Medical IRANICA, 1992
78. Pourmand G. Donor polar kidney arteries: experience with 10 cases among 140
living-related kidney transplants. Transplantation Proceedings. 24(5):1867, October
1992
79. Pourmand G. The mineral compositions of 103 stones from Iran. British Journal of
Urology, Vol. 55 No.5, October 1983
80. NOTE:Pourmand G. Urinary infection before and after prostectomy. Saudi Arabia
Journal(In Press)
� Farsi
81. Pourmand G. The Effect of Renal Transplantation on Improvement of Erectile
dysfunction in hemodialysis patients.Urmia Medical Journal. Vol 18, No 3, Fall
2007: 567-571
82. Pourmand G. Design, fabrication and test of a new self-retaining, standing,
adjustable surgical retractor for abdominal and thoracic surgical operations.Hakim
Research Journal 2007; 9(4): 37-45
83. Pourmand G. Post-Transplantation infectious complication in Iranian kidney
recipients: A prospective study of 142 patients. Scientific Journal School of Public
Health and Institute of Public Health Research, Vol. 4, No. 2, Summer 2006
84. Pourmand G. Response of T cell cytokines to low level He-Ne laser irradiation
invitro: can low level lasers prevent chronic graft rejection? Lasers in Medicine,
Vol.4, No. 4, Spring 2006
85. Pourmand G. Evaluation of bone mineral density in patients with urolithiasis.
Hormozgan Medical Journal No 3, Fall 2005: 157-162
86. Pourmand G. Hematospermia. Medical Journal of Tehran Medical School, Spring
2004
87. Pourmand G.Clinical and laboratory findings of CMV infection in renal
transplant recipients in Sina Hospital.Journal of infectious and tropical
diseases.2003:37-39
88. Pourmand G. Post kidney transplantations: Infectious complications. Today
Iranian Journal of Urology, 16-23, 2003
89. Pourmand G. Genes and gene therapy in oncourology. Iranian Journal of Urology,
Spring 2001
90. Pourmand G. Success rate of ICSI in nonobstructiveAzoospermia. No. 32: 183-
189, Autumn 2001
91. Pourmand G. Evaluation of frequency or aggravation of diabetes mellitus after
renal transplantation in Sina Hospital. Iranian Journal of Endocrinology
&Metabolism , 3, No. 2, Summer 2001
92. Pourmand G. Micro-chimerism in allograft renal recipients: A prospective study.
Iranian Journal of Urology, Winter 2001
93. Pourmand G. Comparison of sperm quality and sex hormone levels in patients
before and after renal transplantation. Iranian Journal of Endocrinology &
Metabolism, 2, No. 4, Winter 2000
94. Pourmand G. Splenosis presenting as an adrenal massIranian Journal of Urology,
No. 27, Fall 2000
95. Pourmand G. Impact of varicocelectey on strict morphology criteria. Iranian
Journal of Urology, No. 25, Spring 2000
96. Pourmand G. Role of urease positive bacteria on infected urinary tract stone
Formation.Journal of infectious and tropical diseases, Winter 1996: 34-39
97. Pourmand G. The 1st clinical report of ESWL in Iran. Journal of Medical Council,
1992
98. Pourmand G. Pheochromocytomain bladder, Medical Journal of Islamic Republic
of Iran, Vol.21. 75-77:1988
99. Pourmand G. Spectroscopy of renal stones in Iran. Journal of Iranian Medical
Council. Vol.9.14-24:1984
100. Pourmand G. Congenital Urethral Diverticulum along with paraurethral diver.
Journal of Tehran Medical School, Vol. 5-6, 95-98, 1981
101. Pourmand G. Ectopic ossification as a nidus for renal stone. Journal of Iranian
Medical Council, Vol 6.467:1978
• Books
1. Pourmand G. Iranian Textbook of Urology. ShahidBeheshti University Publications,
2007
2. Pourmand G. Essential Urology. Tehran University of Medical Sciences Publications,
2003
3. Pourmand G. Organ Transplantation. Special Diseases Center, 2003
4. Pourmand G. Organic Causes of Male Impotency. Tehran University of Medical
Sciences Publications, 1994
• Presentations in National & International Meetings
1. April 09, 2011: Nexavar RCC Expert Workshop, Paris – France
2. November 07-11, 2010: Women's Congress, Tehran – Iran
3. November 02, 2010: Educational workshop on devising local values for specialized
urological services, Tehran – Iran
4. September 27-29, 2010: Workshop for familiarizing new residents of Sina Hospital
(2010-2011), Tehran – Iran
5. October 18-21, 2010: The 12th Congress of the Middle East Society for Organ
Transplantation, Tunis – Tunisia
6. June 30 – July 02, 2010: ISN Nexus Symposium on Fibrosis & the Kidney, CKD
prevalence in rural population of over 30 years in Shahreza in 2009,Geneva –
Switzerland
7. June 24, 2010: Sanofi-Aventis Prostate/Breast Cancers Standalone, Panel & Case
Discussion,Budapest – Hungary
8. June 22, 2010: Iranian Cancer Association, Panel & Case Discussion,Tehran – Iran
9. May 13-16, 2010: The26th Iranian Congress of Radiology, Tehran – Iran
a. Renal Masses
b. Panel: Diagnostic clues and pitfalls in Uroradiology
10. May 2010: The34thAnnual Congress of the Iranian Surgeons Society& the 9th Iranian
Organ Transplantation Scientific Congress, Tehran – Iran
a. Round table: Preparing and removing transplanting organs
b. Imaging in Organ Transplantation
11. April 16-20, 2010: Annual EAU Congress, Barcelona – Spain
a. PTEN gene mutation & primary prostate cancer progression
b. Participation in the Joint Session: Low risk prosthetic carcinoma: Surgery or
surveillance?
12. 2008: Iranian Congress of Renal Transplantation
a. Management of ureteral urologic complications: experience after 1000 kidney
transplantation
b. Does PTN gene play a role in prostate cancer progression?
c. Outcome of 18 cases of simultaneous kidney and donor specific bone marrow
transplantation
d. Does donor nephron mass have any impact on graft survival?
e. Microchimerism and renal transplantation:Doubt still persists.
f. Surgical techniques in treatment of urologic complication after renal
transplantation
g. Pelvic Nerve neuropathy after kidney transplantation
h. The effect of successful renal transplantation on erectile dysfunction
i. Omission of azathioprine and mycophenolatemofetil in
immunosuppressive regimen in kidney transplantation
j. Effect of renal transplantation on sperm quality and sex hormone level
k. The outcome of renal transplantation in 28 patients receiving kidneys with
multiple renal vessels
l. Effect of donor bone marrow cells infusion on alloimunization and kidney
allograft outcome
m. Infectious complications in 142 Persian kidney transplant recipients during
one-year follow-up
13. 2008:The 7th Congress of Iran Organ Transplantation
a. The effect of Successful Renal Transplantation on erectile dysfunction.
b. The effect of Successful Renal Transplantation on Sperm quality and sex
hormones level.
c. Post kidney transplantation hepatitis C virus and its impact on graft and
patient survival.
d. Does donor nephron mass have any impact on graft survival?
e. Surgical techniques in treatment of urologic complication after renal
transplantation.
f. Infectious complications in 142 persiankidney transplant recipients during one
year follow-up
g. Effect of living unrelated donor bone marrow cells infusion on kidney allograft
function.
h. Ureteroscopic management of urological complications after renal
transplantation.
14. 2008: The11th Congress of Iranian Urological Association
a. Serum Selenium level and prostate cancer: A case-control study
b. The effect of low level he-ne laser radiation (4 j/cm2) 632.8 nm on the
secretion of effective cytokine on chronic graft rejection: An invitro study
c. Effect of living unrelated donor bone marrow cells infusion on kidney
allograft function
d. Management of ureteral urologic complications: experience after 700 kidney
transplantation
e. Post kidney transplantation hepatitis C virus and its impact on graft and
patient survival
f. The effect of calcium,magnesium,zinc and copper in blood and seminal
plasma on semen parameters of spinal cord injured men
g. Serum Leptin level and premature ejaculation: A case-control study
h. TUL or ESWL is the approach of choice for upper ureter stones management:
a comparative study
15. 2008: The23rd Annual EAU Congress, Extracorporeal shock wave lithotripsy in
adults: results and short-term complications, Milan – Italy
16. 2008: AUA 2008 Annual Meeting (USA)
a. Extracorporeal shock wave lithotripsy and its effect on renal
function,assessed by 99m Technetium Dethylene-Tiamine-Pentaacetic acid
Scintigraphy
b. The effect of successful renal transplantation on erectile dysfunction
a. 2008: The 2nd International Congress of Medical Ethics in Iran, Ethical
consideration for kidney transplant from deceased patients
17. 2007: The 29th Congress of the Societe International d’urologie (SIU) (Paris –
France)
a. Serum selenium level and prostatecancer : A case-control study
b. TUL or ESWL is the approach of choice for upper ureter stones management:
a comparative study
c. The effect of successful renal transplantation on erectile dysfunction.
18. 2007: EAU 1st Eastern Mediterranean Meeting (Antalya – Turkey)
a. Outcome of 18 cases of simultaneous kidney and donor specific bone marrow
transplantation
b. Serum selenium level and prostate cancer: A case –control study
c. Does PTN gene play a role in prostate cancer progression?
d. Anabolic androgenic steroids effects on early morbid symptoms after open
prostatectomy
e. Prospective study of michrochimerism in renal allograft recipients:
Association between HLA-DR matching,michrochimerism and acute rejection
f. Effect of renal transplantation on sperm quality and sex hormone level
g. The effect of low level He-Ne laser radiation (4J/cm2)632.8nm on the
secretion of effective cytokine on chronic graft rejection-an in vitro study
h. Microchimerism and renal transplantation: Doubt still persists
i. Post kidney transplant hepatitis C virus and its impact on graft and
patient survival
j. Does donor nephron mass have any impact on graft survival?
k. Urinary tamm-horsfall protein and other inhibitors and promotors of calcium
stone formation: A case-control study
l. TUL or ESWL is the approach of choice for upper ureteral stones
management: A comparative study
m. Evaluation of sperm nuclear chromatin condensation in infertile patients
with spinal cord injury varicocele and healthy individuals
19. 2007: The 13th Congress of The European Society for Organ Transplantation (ESOT)
a. Surgical techniques in treatment of urologic complication after renal
transplantation
b. Does donor nephron mass have any impact on graft survival?
c. Improvement of erectile dysfunction after kidney transplantation the role of
associated factor
d. Effect of living unrelated donor bone marrow cells infusion of kidney allograft
function
e. Post kidney transplant hepatitis C virus and its impact on graft and patient
survival
f. Role of resistive index measurement in diagnosis of acute rejection after renal
transplantation
20. 2007:The19th Asia Pacific Cancer Congress, Screening for prostate cancer, Tehran –
Iran
21. 2007: The 44th ERA-EDTA Congress (Barcelona, Spain)
a. Prevalance of metabolic abnormalities of calcium in pateints with urinary
stone in south Iran
b. Effect of renal transplantation on sperm quality and sex hormones level
c. Prospective study of microchimerism in renal allograft recipients: Association
between HLA DR matching, microchimerism and acute rejection.
d. Role of resistive index measurement in diagnosis of acute rejection after renal
transplantation .
e. Ureteroscopic management of urological complications after renal
transplantation
22. 2007: The7th International Congress on Obstetrics and Gynecology,Nanogyncology,
Iran
23. 2007: The 11th International Congress of Nephrology, Dialysis and Transplantation,
Iran
a. Effect of living unrelated donor bone marrow cells infusion on kidney
allograft function
b. Post kidney transplant hepatitis C virus and its impact on graft and patient
survival
24. 2007: The 10th Iranian Urological Ass. Congress, TUL or ESWL is the approach of
choice for upper ureteral stones management: A comparative study
25. 2007:Vascular Surgery and Diabetics Mellitus Congress, Diabetes and kidney
transplantation, Tehran – Iran
26. 2007:XLIV-EDTA Congress (Spain), Prospective study of microchimerism in renal
allograft recipients: Association between HLA DR matching, microchimerism and
acute rejection
27. 2006:The10th Congress of the Middle East Society for Organ Transplantation, Kuwait
a. The effect of successful renal transplantation on erectile dysfunction
b. Surgical techniques in treatment of urologic complication after renal
transplantation
28. 2006: The 28th Congress of the SocieteInternationaled’Urologie, South Africa
a. Seminal plasma magnesium and premature ejaculation: a case-control study
b. Does PTEN gene play a role in prostate cancer progression?
c. The impact of nandrolone on post prostatectomy bothersome symptoms
d. Comparison of urinary proteins in calcium stone formers and healthy
individuals: a case-control study
e. Ureteroscopic management of ureteral injury during gynecological surgery
f. Preoperative corporal biopsy can predict postoperative results in
venoocclusive erectile dysfunction
g. The relationship between lipid profile and erectile dysfunction
29. 2006: The 21st Congress of the European Association of Urology (EAU),
Microchimerism and Renal Transplantation: Doubt Still Persists, Paris – France
30. 2006: The 31st Congress of the Federation-of-European-Biochemical-Societies
(FEBS) Istanbul, Turkey
a. Prevalence intron 1 duplication among patients susceptible to primary
hyperoxaluria type 1 in Iran
31. 2006: The10th Iranian Annual Congress of Nephrology, Dialysis and
Transplantation
a. A nationwide case-control study for identifying the risk factors for
tuberculosis following renal transplantation
b. Guillan - Barre Syndrome after renal transplantation
32. 2006: The Iranian Medical Students Nano Congress Seminar. Applied Nano Medicine
33. 2006: The 43rd Annual congress of the European-Renal-Association/ European-
Dialysis-and-Transplant Association (ERA-EDTA) Glasgow, Scotland
a. Outcome of 18 cases of simultaneous kidney and donor- specific bone marrow
transplantation.
b. Endourological interventions used to treat urological complications in 700
kidney recipients.
c. Prospective study of microchimerism in renal allograft recipients.Association
between HLA DR matching, microchimerism and acute rejection
d. Prevalance of metabolic abnormalities of calcium in pateints with urinary
stone in south Iran
e. Omission of azathioprine and mycophenolatemofetil in immunosuppressive
regimen in kidney transplantation
f. Incidence of post renal Transplantation hyperlipidemia and its long term
impact on patients and graft survival
g. Effect of renal transplantation on sperm quality and sex hormones level
34. 2005:The 42ndAnnual Congress of the European-Renal-Association/ European-
Dialysis-and-Transplant Association (ERA-EDTA)Istanbul,Turkey
a. .Effect of donor kidney mass on graft survival in renal transplantation
b. Prevalance of metabolic abnormalities of calcium in patients with urinary
stone in south Iran
c. Prospective study of microchimerism in renal allograft recipients: Association
between HLA DR matching, microchimerism and acute rejection.
d. Effect of renal transplantation on sperm quality and sex hormones level
35. 2005: Nano Medicine in Obstetrics & Gynecology
36. 2005: The General Secretary of Energy in Endourology
37. September 13 – 15, 2005:The 9th European Symposium on Urolithiasis, Rotterdam –
The Netherlands
a. The Infrared Spectroscopic Analyses of 241 Iranian Urinary Stones
b. Comparison of Urine Culture Proximal to Stone with Preoperative Urine
Culture
38. March 16 – 19, 2005:The XXth Congress of the European Association of Urology,
Istanbul – Turkey
a. Catherter-free suprapubicprostatectmy: a novel technique
b. Effect of donor kidney mass on graft survival in renal transplantation
c. Do cigarette smokers with erectile dysfunction benefit from quitting?
d. Selective Evaluation of two urinary enzymes (NAG and AAP) before and after
unilateral shock wave lithotripsy
39. October 3 – 7, 2004: The XthCongress of the SocieteInternationaled, Urologie (SIU),
Hawaii – USA
a. Urinary Tam-Horsfall protein, inhibitors and promoters of calcium stone
formation: a case- control study
b. Ras and p53 gene mutations in Iranian bladder cancer
c. Erectile dysfunction in patients with coronary artery disease
d. Role of resistive index measurement in diagnosis of acute rejection after renal
transplant
e. The effect of electroejaculation on the quality and quantity of seminal fluid
and sperm of spinal cord injured (SCI) men in comparison with normal fertile
men
f. Endourological interventions used to treat urologicalcomplications in 700
kidney recipients
g. VII- Clinical correlation of unilateral testicular hypotrophy and semen quality
h. Relation between erectile dysfunction and blood lipids: a case- control study
40. 2004: AUA 2004 annual meeting (San Francisco,CA)
a. Bone mineral density evaluation in urolithiasis
41. 2004:The 9th International Congress of the Middle East society for organ
transplantation, Ankara – Turkey
a. Omission of azathioprine and mycophenolatemofetil in immunosuppressive
regimen in kidney transplantation
b. Preliminary report of a nationwide case control study for identifying the risk
factors of tuberculosis following renal transplantation
c. Microchimerism and renal transplantation: doubt still persists
d. To study the risk factors for post- transplant diabetes mellitus
42. April 22 – 24, 2004:The 9th International Congress of the Middle East Society for
Organ Transplantation, Tehran – Iran
a. Post kidney transplant Hepatitis C virus and Its impact on graft and patient
survival
b. Surgical Techniques in Treatment of Urologic Complications
c. Kidney transplantation and diabetes mellitus
43. 2003: Genetics in urology. The 1st Iranian International Congress on Medical
Genetics
44. 2003: Arbiter in the 9thRazi Medical Research Festival
45. September 21 – 24, 2003:The 11th Congress of the European Society for Organ
Transplantation,VeniceLido – Italy
46. September 20 – 22, 2003:The 13th Congress of the European Transplant
Coordinators Organization,VeniceLido – Italy
47. 2003:EUA,Madrid – Spain
48. 2003:EDTA Congress,Denmark
49. 2002: Arbiter in the 8thRazi Medical Research Festival
50. 2002: Physician and forensic medicine. The International Congress on Forensic
Medicine
51. September 8 – 12, 2002:The 26th Congress of the SocieteInternationale d’ Urologic,
Stockholm – Sweden
a. Prospective study of microchimerism in renal allograft recipients.Association
between HLA DR matching, microchimerism and acute rejection
b. Kidney transplantation and diabetes mellitus
c. Effect of renal transplantation on sperm quality and sex hormones level and
sexual function
d. Evaluation of endourological intervention used to treat urological
complications in 394 kidney recipients
e. Effect of sex of donor blood group and age difference between donor and
recipient on early acute rejection in 370 renal transplantations
52. October 21 – 24,2002:The VIII International Congress of the MESOT, Oman
53. September 8 – 12,2002: The 26thSIU, Stockholm – Sweden
54. September 13-15, 2001:The 9th European Symposium on Urolithiasis, Rotterdam –
The Netherlands
a.Comparison of Urine Culture Proximal to stone with preoperative urine culture..
b. The Infrared Spectroscopic Analyses of 209 Iranian urinary stones.
C. Prevalence of metabolic abnormalities of Calcium in patients with urinary stone in
South of Iran.
d.Effect of nasal desmopressin on the treatment of acute renal colic.
55. 2001:International Congress of the Middle East Society for Organ Transplantation,
Stockholm – Sweden
a. Patient blood glucose levels before and after kidney transplantation
b. Incidence of post renal Transplantation hyperlipidemia and its long term
impact on patients and graft survival
c. Evaluation of endourological interventions used to treat urological
complications in 394 kidney recipients
d. The outcome of renal transplantation in 23 patients receiving kidneys with
aberrant or accessory vessels
e. Impact of donor Nephron mass on outcome in renal transplantation
f. Alternations in standard immunosuppressive regimen in kidney transplanted
patients and its effects on graft survival
g. Post kidney transplant hepatitis C Virus and its impact on graft and patient
survival
56. 2001-02: Workshop on Scientific Writing
57. 2001:25 years in Renal Transplantation, Ankara – Turkey
58. 2001:The European Association of Organ Transplantation, Lisbon – Portugal
59. 2001:Premature Ejaculation. The 5th Iranian Urological Association Congress
60. 2001: Gene therapy in Urological Cancers. The 6th Iranian Urological Association
Congress
61. 2000: Infection in children. The Iranian Congress on Urinary Infection in Newborns
and children
62. 2000:Middle East Organ Transplantation Congress, Beirut – Lebanon
63. 1999:Middle East Organ TransplantationCongress, Isfalan – Iran
64. 1999:The 8thUrolithiasis Symposium, Parma – Italy
65. 1999:The First Iranian Organ Transplantation Congress, Iran
66. 1999:The 23rd Congress of SIU, Sydney - Australia
67. 1999:The 4th International Urological Congress, Iran
68. 1999:The 25th Congress of the SocieteInternationale d’ Urologie, Stockholm –
Sweden
a. Chromosomal studies of 222 infertile males in Tehran
b. Intra-Cytoplasmic Sperm Injection for Non-obstructiveAzoospermia
69. 1998:Update in Nephrology Course, Dubai – UAE
70. 1997:The 4th Turkish Organ Transplant, Ankara – Turkey
71. 1997:The 24th Congress of the SocieteInternationale d’ Urologic, Montreal – Canada
a. Evaluation of Acute kidney Rejection in 151 Recipients
b. The Incidence of Infected Stones and their Relationship to Urease Positive
Bacteria
72. 1997:The 15th World Congress on Endourology, Edinburgh – Scotland, UK
a. Evaluation of the Clinical and Urodynamic Effects of pygeumAfricanum
(TADENAN) in the Treatment of Benign Prostatic Hyperplasia (BPH)
b. Utilizing of N-Acetyl-Glucosaminidase (NAG) &AlaninAminopeptidase (AAP)
Urinary Enzymes to Evaluate Kidney Parenchymal Injury Following
Extracorporeal Shock wave Lithotripsy (ESWL)
73. 1997:Nuclear Scintigraphy EAU Congress, Paris – France
a. The Earty Effect of Electromagnetic Lithotripsy on Renal Function Assessed
by Nuclear Scintigraphy EAU Congress
b. Traumatic Rupture of Penile Tunica Albuginea: Management and impact on
Erectile Function, EAU Congress Pris, France
74. 1996:The Xllth EAU Congress, Paris – France
75. 1996:Visiting the Nephrology Department of PISA University, Italy
76. 1996:The 5th Middle East Society for Organ Transplantation,Lipid and Lipoproteins
alterations after Renal Transplantation, Limassol – Cyprus
77. 1994:Xth World Congress of Endourology,Louisiana – USA
a. Bacteriuria and Extracorporeal shock wave lithotripsy Prophylaxis and
treatment
b. Extracorporeal shock wave Iithotripsy in Horseshoe kidneys
78. 1992:Xth Congress European Ass. Urology,Early Repair of Urological injuries
following pelvic Surgery, Italy
79. 1992:The Xth Congress of Eurpoean Ass. Urology, Italy
80. 1991:Ethics, Justice & Commerce in Organ Transplantation, Munich – Germany
81. 1991:SThe 22nd International Urological Congress,Complex Post. Urethral Stricture,
Servilla - Spain
82. 1990:Middle East Organ Transplantation,Urological Complications in Transplanted
Kidneys, Mesot–Kuwait
83. 1990:The 2nd International Urological Seminar,Tubed Versus Tubeless Pyeloplasty,
Tabriz – Iran
84. 1989:The 3rd Annual Avicenna Medical Congress,Management of Urological
Complications in Kidney Transplant, Tehran – Iran
85. 1989:Lithotripsy Meeting, Dubai – UAE
86. 1988:American Urological Association (Annual meeting), Dallas – USA
87. 1988: The 2nd Annual Avicenna Medical Congress,Ureteral folding versus Ureteral
tailoring in management of megaureter, Tehran –Iran
88. 1987: The 1st International Urological Seminar,Omental Graft in complicated
vesicovagingl fistulae, Tehran – Iran
89. 1987: The 1st International Urological Seminar,Evaluation of
TranspublicUrethroplasty, Tehran – Iran
90. 1986: The 1st Annual Avicenna Medical Congress,Ureteral folding versus Ureteral
tailoring in management of megaureter, Iran
91. 1977:The British Association of Urological Surgeons, Aberdeen – UK
Grants:
Completed Grants
• Pharmacokinetics, efficacy, and safety of Iminoral compared with Neoral in healthy
volunteers and Renal Transplant recipients (September 4, 2005 – July 10, 2006) with
ZahraviPharma Company
Pending Grants
• Result of prostate biopsy on the basis of Total PSA (free PSA , PSA D) accompany
with prostate cancer risk factors , in Iranian patients ( September 23, 2007 up to
now) withMinistry Of Health and Medical Education
Awards:
• The 2ndRoyan International Research Award
• Special Diseases Foundation “Letter of Appreciation”
• Shiraz Janbazan Organization “Letter of Appreciation”, Supervisor of the Examining
Board (Ministry of Health and Medical Eduacation)
• The 7thRazi Festival Award (National Research Center of Medical Sciences), First
Rank – Clinical Sciences
• The 11thRazi Festival Award, First Rank – Invention, Innovation, Novelty and
Scientific Hypothesis
Competencies:
• Language
o Moderate English